+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Insulin Market 2023-2027

  • PDF Icon

    Report

  • 154 Pages
  • December 2022
  • Region: Global
  • TechNavio
  • ID: 5712875
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the insulin market and is forecast to grow by $1662.41 mn during 2022-2027, accelerating at a CAGR of 1.77% during the forecast period. The publisher's report on the insulin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of diabetes, increasing exposure to risk factors that lead to diabetes, and favorable government initiatives.

The publisher's insulin market is segmented as below

By Type

  • Insulin analog
  • Human insulin

By Distribution Channel

  • Retail pharmacies
  • Hospitals
  • Online pharmacies

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advances in insulin delivery systems as one of the prime reasons driving the insulin market growth during the next few years. Also, increasing focus on home care settings and an increase in awareness of diabetes and growth initiatives will lead to sizable demand in the market.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The publisher's report on the insulin market covers the following areas:

  • Insulin market sizing
  • Insulin market forecast
  • Insulin market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading insulin market vendors that include AdvaCare Pharma, ASP Healthcare Pty Ltd., B. Braun SE, Becton Dickinson and Co., Biocon Ltd., Cardinal Health Inc., CODAN Medizinische Gerate GmbH and Co KG, Eli Lilly and Co., Gerresheimer AG, Gulf Pharmaceutical Industries, Healthwarehouse.com Inc., Hindustan Syringes and Medical Devices Ltd., Hi Tech Medics Pvt Ltd., Mayo Foundation for Medical Education and Research, Novo Nordisk AS, Pfizer Inc., Sanofi SA, UltiMed Inc., Wockhardt Ltd., and Nipro Corp. Also, the insulin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global insulin market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global insulin market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Distibution channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distibution channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Insulin analog - Market size and forecast 2022-2027
Exhibit 34: Chart on Insulin analog - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Insulin analog - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Insulin analog - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Insulin analog - Year-over-year growth 2022-2027 (%)
6.4 Human insulin - Market size and forecast 2022-2027
Exhibit 38: Chart on Human insulin - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Human insulin - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Human insulin - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Human insulin - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 43: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 44: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 45: Chart on Comparison by Distribution Channel
Exhibit 46: Data Table on Comparison by Distribution Channel
7.3 Retail pharmacies - Market size and forecast 2022-2027
Exhibit 47: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
7.4 Hospitals - Market size and forecast 2022-2027
Exhibit 51: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
7.5 Online pharmacies - Market size and forecast 2022-2027
Exhibit 55: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 59: Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 63: Chart on Geographic comparison
Exhibit 64: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 101: Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 102: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 104: Overview on factors of disruption
11.4 Industry risks
Exhibit 105: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 106: Vendors covered
12.2 Market positioning of vendors
Exhibit 107: Matrix on vendor position and classification
12.3 B. Braun SE
Exhibit 108: B. Braun SE - Overview
Exhibit 109: B. Braun SE - Business segments
Exhibit 110: B. Braun SE - Key news
Exhibit 111: B. Braun SE - Key offerings
Exhibit 112: B. Braun SE - Segment focus
12.4 Becton Dickinson and Co.
Exhibit 113: Becton Dickinson and Co. - Overview
Exhibit 114: Becton Dickinson and Co. - Business segments
Exhibit 115: Becton Dickinson and Co. - Key news
Exhibit 116: Becton Dickinson and Co. - Key offerings
Exhibit 117: Becton Dickinson and Co. - Segment focus
12.5 Biocon Ltd.
Exhibit 118: Biocon Ltd. - Overview
Exhibit 119: Biocon Ltd. - Business segments
Exhibit 120: Biocon Ltd. - Key offerings
Exhibit 121: Biocon Ltd. - Segment focus
12.6 Cardinal Health Inc.
Exhibit 122: Cardinal Health Inc. - Overview
Exhibit 123: Cardinal Health Inc. - Business segments
Exhibit 124: Cardinal Health Inc. - Key news
Exhibit 125: Cardinal Health Inc. - Key offerings
Exhibit 126: Cardinal Health Inc. - Segment focus
12.7 CODAN Medizinische Gerate GmbH and Co KG
Exhibit 127: CODAN Medizinische Gerate GmbH and Co KG - Overview
Exhibit 128: CODAN Medizinische Gerate GmbH and Co KG - Product/Service
Exhibit 129: CODAN Medizinische Gerate GmbH and Co KG - Key offerings
12.8 Eli Lilly and Co.
Exhibit 130: Eli Lilly and Co. - Overview
Exhibit 131: Eli Lilly and Co. - Product/Service
Exhibit 132: Eli Lilly and Co. - Key offerings
12.9 Gerresheimer AG
Exhibit 133: Gerresheimer AG - Overview
Exhibit 134: Gerresheimer AG - Business segments
Exhibit 135: Gerresheimer AG - Key news
Exhibit 136: Gerresheimer AG - Key offerings
Exhibit 137: Gerresheimer AG - Segment focus
12.10 Gulf Pharmaceutical Industries
Exhibit 138: Gulf Pharmaceutical Industries - Overview
Exhibit 139: Gulf Pharmaceutical Industries - Product/Service
Exhibit 140: Gulf Pharmaceutical Industries - Key offerings
12.11 Hindustan Syringes and Medical Devices Ltd.
Exhibit 141: Hindustan Syringes and Medical Devices Ltd. - Overview
Exhibit 142: Hindustan Syringes and Medical Devices Ltd. - Product/Service
Exhibit 143: Hindustan Syringes and Medical Devices Ltd. - Key offerings
12.12 Mayo Foundation for Medical Education and Research
Exhibit 144: Mayo Foundation for Medical Education and Research - Overview
Exhibit 145: Mayo Foundation for Medical Education and Research - Product/Service
Exhibit 146: Mayo Foundation for Medical Education and Research - Key offerings
12.13 Nipro Corp.
Exhibit 147: Nipro Corp. - Overview
Exhibit 148: Nipro Corp. - Business segments
Exhibit 149: Nipro Corp. - Key offerings
Exhibit 150: Nipro Corp. - Segment focus
12.14 Novo Nordisk AS
Exhibit 151: Novo Nordisk AS - Overview
Exhibit 152: Novo Nordisk AS - Business segments
Exhibit 153: Novo Nordisk AS - Key offerings
Exhibit 154: Novo Nordisk AS - Segment focus
12.15 Pfizer Inc.
Exhibit 155: Pfizer Inc. - Overview
Exhibit 156: Pfizer Inc. - Product/Service
Exhibit 157: Pfizer Inc. - Key news
Exhibit 158: Pfizer Inc. - Key offerings
12.16 Sanofi SA
Exhibit 159: Sanofi SA - Overview
Exhibit 160: Sanofi SA - Business segments
Exhibit 161: Sanofi SA - Key news
Exhibit 162: Sanofi SA - Key offerings
Exhibit 163: Sanofi SA - Segment focus
12.17 Wockhardt Ltd.
Exhibit 164: Wockhardt Ltd. - Overview
Exhibit 165: Wockhardt Ltd. - Business segments
Exhibit 166: Wockhardt Ltd. - Key offerings
Exhibit 167: Wockhardt Ltd. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 168: Inclusions checklist
Exhibit 169: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 170: Currency conversion rates for US$
13.4 Research methodology
Exhibit 171: Research methodology
Exhibit 172: Validation techniques employed for market sizing
Exhibit 173: Information sources
13.5 List of abbreviations
Exhibit 174: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global insulin market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Distibution channel Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Type - Market share 2022-2027 (%)
Exhibits 31: Data Table on Type - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Insulin analog - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Insulin analog - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Insulin analog - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Insulin analog - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Human insulin - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Human insulin - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Human insulin - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Human insulin - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Type ($ million)
Exhibits 43: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits 44: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits 45: Chart on Comparison by Distribution Channel
Exhibits 46: Data Table on Comparison by Distribution Channel
Exhibits 47: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 50: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 51: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 55: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 56: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 58: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits 59: Market opportunity by Distribution Channel ($ million)
Exhibits 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 63: Chart on Geographic comparison
Exhibits 64: Data Table on Geographic comparison
Exhibits 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 101: Market opportunity By Geographical Landscape ($ million)
Exhibits 102: Impact of drivers and challenges in 2022 and 2027
Exhibits 103: Overview on Criticality of inputs and Factors of differentiation
Exhibits 104: Overview on factors of disruption
Exhibits 105: Impact of key risks on business
Exhibits 106: Vendors covered
Exhibits 107: Matrix on vendor position and classification
Exhibits 108: B. Braun SE - Overview
Exhibits 109: B. Braun SE - Business segments
Exhibits 110: B. Braun SE - Key news
Exhibits 111: B. Braun SE - Key offerings
Exhibits 112: B. Braun SE - Segment focus
Exhibits 113: Becton Dickinson and Co. - Overview
Exhibits 114: Becton Dickinson and Co. - Business segments
Exhibits 115: Becton Dickinson and Co. - Key news
Exhibits 116: Becton Dickinson and Co. - Key offerings
Exhibits 117: Becton Dickinson and Co. - Segment focus
Exhibits 118: Biocon Ltd. - Overview
Exhibits 119: Biocon Ltd. - Business segments
Exhibits 120: Biocon Ltd. - Key offerings
Exhibits 121: Biocon Ltd. - Segment focus
Exhibits 122: Cardinal Health Inc. - Overview
Exhibits 123: Cardinal Health Inc. - Business segments
Exhibits 124: Cardinal Health Inc. - Key news
Exhibits 125: Cardinal Health Inc. - Key offerings
Exhibits 126: Cardinal Health Inc. - Segment focus
Exhibits 127: CODAN Medizinische Gerate GmbH and Co KG - Overview
Exhibits 128: CODAN Medizinische Gerate GmbH and Co KG - Product/Service
Exhibits 129: CODAN Medizinische Gerate GmbH and Co KG - Key offerings
Exhibits 130: Eli Lilly and Co. - Overview
Exhibits 131: Eli Lilly and Co. - Product/Service
Exhibits 132: Eli Lilly and Co. - Key offerings
Exhibits 133: Gerresheimer AG - Overview
Exhibits 134: Gerresheimer AG - Business segments
Exhibits 135: Gerresheimer AG - Key news
Exhibits 136: Gerresheimer AG - Key offerings
Exhibits 137: Gerresheimer AG - Segment focus
Exhibits 138: Gulf Pharmaceutical Industries - Overview
Exhibits 139: Gulf Pharmaceutical Industries - Product/Service
Exhibits 140: Gulf Pharmaceutical Industries - Key offerings
Exhibits 141: Hindustan Syringes and Medical Devices Ltd. - Overview
Exhibits 142: Hindustan Syringes and Medical Devices Ltd. - Product/Service
Exhibits 143: Hindustan Syringes and Medical Devices Ltd. - Key offerings
Exhibits 144: Mayo Foundation for Medical Education and Research - Overview
Exhibits 145: Mayo Foundation for Medical Education and Research - Product/Service
Exhibits 146: Mayo Foundation for Medical Education and Research - Key offerings
Exhibits 147: Nipro Corp. - Overview
Exhibits 148: Nipro Corp. - Business segments
Exhibits 149: Nipro Corp. - Key offerings
Exhibits 150: Nipro Corp. - Segment focus
Exhibits 151: Novo Nordisk AS - Overview
Exhibits 152: Novo Nordisk AS - Business segments
Exhibits 153: Novo Nordisk AS - Key offerings
Exhibits 154: Novo Nordisk AS - Segment focus
Exhibits 155: Pfizer Inc. - Overview
Exhibits 156: Pfizer Inc. - Product/Service
Exhibits 157: Pfizer Inc. - Key news
Exhibits 158: Pfizer Inc. - Key offerings
Exhibits 159: Sanofi SA - Overview
Exhibits 160: Sanofi SA - Business segments
Exhibits 161: Sanofi SA - Key news
Exhibits 162: Sanofi SA - Key offerings
Exhibits 163: Sanofi SA - Segment focus
Exhibits 164: Wockhardt Ltd. - Overview
Exhibits 165: Wockhardt Ltd. - Business segments
Exhibits 166: Wockhardt Ltd. - Key offerings
Exhibits 167: Wockhardt Ltd. - Segment focus
Exhibits 168: Inclusions checklist
Exhibits 169: Exclusions checklist
Exhibits 170: Currency conversion rates for US$
Exhibits 171: Research methodology
Exhibits 172: Validation techniques employed for market sizing
Exhibits 173: Information sources
Exhibits 174: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global insulin market: AdvaCare Pharma, ASP Healthcare Pty Ltd., B. Braun SE, Becton Dickinson and Co., Biocon Ltd., Cardinal Health Inc., CODAN Medizinische Gerate GmbH and Co KG, Eli Lilly and Co., Gerresheimer AG, Gulf Pharmaceutical Industries, Healthwarehouse.com Inc., Hindustan Syringes and Medical Devices Ltd., Hi Tech Medics Pvt Ltd., Mayo Foundation for Medical Education and Research, Novo Nordisk AS, Pfizer Inc., Sanofi SA, UltiMed Inc., Wockhardt Ltd., and Nipro Corp.

Commenting on the report, an analyst from the publisher said: 'The latest trend gaining momentum in the market is advances in insulin delivery systems.'

According to the report, one of the major drivers for this market is the growing prevalence of diabetes.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AdvaCare Pharma
  • ASP Healthcare Pty Ltd.
  • B. Braun SE
  • Becton Dickinson and Co.
  • Biocon Ltd.
  • Cardinal Health Inc.
  • CODAN Medizinische Gerate GmbH and Co KG
  • Eli Lilly and Co.
  • Gerresheimer AG
  • Gulf Pharmaceutical Industries
  • Healthwarehouse.com Inc.
  • Hindustan Syringes and Medical Devices Ltd.
  • Hi Tech Medics Pvt Ltd.
  • Mayo Foundation for Medical Education and Research
  • Novo Nordisk AS
  • Pfizer Inc.
  • Sanofi SA
  • UltiMed Inc.
  • Wockhardt Ltd.
  • Nipro Corp.

Related Topics

Related Reports

Global Insulin Syringes Market 2024-2028 - Product Image

Global Insulin Syringes Market 2024-2028

  • Report
  • 139 Pages
  • Global
From
Rapid Acting Insulin Market Report by Product, Indication, Distribution Channel, and Region 2024-2032 - Product Image

Rapid Acting Insulin Market Report by Product, Indication, Distribution Channel, and Region 2024-2032

  • Report
  • 135 Pages
  • Global
From
Insulin Pens - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Insulin Pens - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • 100 Pages
  • Global
From
Insulin Infusion Pumps - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Insulin Infusion Pumps - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Human Insulin Market Report by Product Type (Drugs, Delivery Devices), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Retail Stores, and Others), Disease Type (Type I Diabetes, Type II Diabetes), and Region 2024-2032 - Product Image

Human Insulin Market Report by Product Type (Drugs, Delivery Devices), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Retail Stores, and Others), Disease Type (Type I Diabetes, Type II Diabetes), and Region 2024-2032

  • Report
  • 149 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.